Dear Doctor - Participate in the Survey on metoprolol " A new survey has found that the vast majority of people who take the blood pressure medication metoprolol are satisfied with the results. The survey, which was conducted by Consumer Reports, polled more than 1,000 people who were taking metoprolol and found that 92% were satisfied with the drug.Metoprolol is a beta-blocker that is typically used to treat hypertension, or high blood pressure. It works by blocking the action of certain hormones in the body that can raise blood pressure. Beta-blockers are some of the most commonly prescribed medications for hypertension, and metoprolol is one of the most popular choices.The Consumer Reports survey found that people who took metoprolol felt it was effective in lowering their blood pressure and reducing their risk of heart attack or stroke. They also reported few side effects from the drug. The most common side effect reported was fatigue, but only 10% of those surveyed said it was a problem for them.Overall, the survey found that metoprolol is an effective and well-tolerated medication for hypertension. If you are taking metoprolol or considering starting on this medication, be sure to speak to your doctor about your specific situation to see if it is right for you. Participate in Surveys "
1.
Retired Olympic athletes at greater risk of skin cancer and osteoarthritis, research reveals
2.
Three Cycles of Chemo Noninferior to Six for Rare Childhood Eye Cancer
3.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
4.
Year in Review: Non-Small Cell Lung Cancer
5.
Electronic Sepsis Alerts; Reducing Plaques in Coronary Arteries
1.
What Is Carboxyhemoglobin And How Can It Affect Your Health?
2.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
3.
Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment
4.
The Technological Revolution in Precision Oncology and Tumor Microenvironment Therapy
5.
The Importance of Having a Quick and Effective Heparin Antidote
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation